Pancreatic Cancer Research

ResearcherMemorial Sloan Kettering Cancer CenterNo recent work listed

Kelly E. Henry

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8492-9364; OpenAlex author ID A5058237659. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: 2 papers

Papers 3

  1. ERK Inhibition Improves Anti-PD-L1 Immune Checkpoint Blockade in Preclinical Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/1535-7163.mct-20-1112↗
  2. Exploiting the MUC5AC Antigen for Noninvasive Identification of Pancreatic Cancer. Co-author DOI 10.2967/jnumed.120.256776↗
  3. A PET Imaging Strategy for Interrogating Target Engagement and Oncogene Status in Pancreatic Cancer. Co-author DOI 10.1158/1078-0432.ccr-18-1485↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jason Stuart Lewis · 3 shared papers, 2019–2021 · strength 0.34
  2. Nagavarakishore Pillarsetty · 1 shared paper, 2021 · strength 0.13
  3. Jan Grimm · 1 shared paper, 2021 · strength 0.11
  4. Bence Sipos · 1 shared paper, 2021 · strength 0.11
  5. Susanne Klein‐Scory · 1 shared paper, 2021 · strength 0.11
  6. Barbara Sitek · 1 shared paper, 2021 · strength 0.11
  7. Holger Kalthoff · 1 shared paper, 2021 · strength 0.11
  8. Michael J. Evans · 1 shared paper, 2019 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.